Table 1 Association between PCDHGA9 expression and clinicopathologic features in 66 gastric cancer patients.
Characteristics | No | Expression | p-value | |
|---|---|---|---|---|
High | Low | |||
Age (years) | 0.586 | |||
<65 | 34 | 15 | 19 | |
≥65 | 32 | 14 | 18 | |
Sex | 0.246 | |||
Female | 27 | 10 | 17 | |
Male | 39 | 19 | 20 | |
Location | 0.906 | |||
Gastric fundus | 3 | 1 | 2 | |
Gastric corpus | 28 | 12 | 16 | |
Pylorus | 35 | 16 | 19 | |
Tumour size (cm) | 0.011 | |||
<3 | 17 | 12 | 5 | |
≥3 | 49 | 17 | 32 | |
UICC stage | <0.001 | |||
I + II | 25 | 24 | 1 | |
III + IV | 41 | 5 | 36 | |
Lymph node metastasis | <0.001 | |||
No | 16 | 15 | 1 | |
Yes | 50 | 14 | 36 | |
Differentiation | <0.001 | |||
High + Moderate | 17 | 16 | 1 | |
Low | 49 | 13 | 36 | |
Methylation | 0.033 | |||
Methylated | 30 | 9 | 21 | |
Unmethylated | 36 | 20 | 16 | |
